Michael D'Angelica

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Ann Surg Oncol 14:759-65. 2007
  2. pmc Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer
    Hiromichi Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America Department of Surgery, Michigan State University, East Lansing, Michigan, United States of America
    PLoS ONE 8:e81680. 2013
  3. pmc Patterns of initial recurrence in completely resected gastric adenocarcinoma
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 240:808-16. 2004
  4. ncbi request reprint Analysis of the extent of resection for adenocarcinoma of the gallbladder
    Michael D'Angelica
    Hepatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 16:806-16. 2009
  5. doi request reprint Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:1096-103. 2011
  6. ncbi request reprint Actual 10-year survival after resection of colorectal liver metastases defines cure
    James S Tomlinson
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 25:4575-80. 2007
  7. ncbi request reprint Randomized clinical trials in advanced and metastatic colorectal carcinoma
    Michael I Dangelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Surg Oncol Clin N Am 11:173-91, ix. 2002
  8. doi request reprint Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy
    Catha Fischer
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    JAMA Surg 148:1103-8. 2013
  9. pmc Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy
    Stephen R Grobmyer
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 244:260-4. 2006
  10. ncbi request reprint Caudate hepatectomy for cancer: a single institution experience with 150 patients
    William G Hawkins
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 200:345-52. 2005

Detail Information

Publications99

  1. ncbi request reprint Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Ann Surg Oncol 14:759-65. 2007
    ..Perioperative bev is now commonly used in patients undergoing hepatic resection. Little is known, however, about the safety of perioperative bev use in the setting of hepatic resection...
  2. pmc Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer
    Hiromichi Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America Department of Surgery, Michigan State University, East Lansing, Michigan, United States of America
    PLoS ONE 8:e81680. 2013
    ..The aim of this study was to build a molecular prognostic model based on gene signatures for patients with completely resected hepatic metastases from colorectal cancer (MCRC)...
  3. pmc Patterns of initial recurrence in completely resected gastric adenocarcinoma
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 240:808-16. 2004
    ..To review recurrence patterns in completely resected gastric adenocarcinoma...
  4. ncbi request reprint Analysis of the extent of resection for adenocarcinoma of the gallbladder
    Michael D'Angelica
    Hepatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 16:806-16. 2009
    ..Major hepatic resections, including major hepatectomy and CBD excision, are appropriate when necessary to clear disease but are not mandatory in all cases...
  5. doi request reprint Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:1096-103. 2011
    ..Despite improvements in surgery and chemotherapy, most patients develop recurrence after hepatectomy for metastatic colorectal cancer. Data are lacking on the effect of these patterns on outcome...
  6. ncbi request reprint Actual 10-year survival after resection of colorectal liver metastases defines cure
    James S Tomlinson
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 25:4575-80. 2007
    ..There is now sufficient follow-up on a significant number of patients to address the curative intent of resecting CLM...
  7. ncbi request reprint Randomized clinical trials in advanced and metastatic colorectal carcinoma
    Michael I Dangelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Surg Oncol Clin N Am 11:173-91, ix. 2002
    ..The advent of irinotecan has given us hope for a second line chemotherapeutic agent and a possible new combination for first line chemotherapy...
  8. doi request reprint Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy
    Catha Fischer
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    JAMA Surg 148:1103-8. 2013
    ..Portal vein embolization improves the safety of liver resection by increasing the size of residual liver, but the embolization may increase tumor growth during the waiting period before definitive hepatectomy...
  9. pmc Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy
    Stephen R Grobmyer
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 244:260-4. 2006
    ..To assess the value of preoperative imaging studies and the intraoperative assessment of perihepatic lymph nodes in patients undergoing partial hepatectomy for malignancy...
  10. ncbi request reprint Caudate hepatectomy for cancer: a single institution experience with 150 patients
    William G Hawkins
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 200:345-52. 2005
    ..Our objective was to assess our results with resection of the caudate lobe of the liver for malignant disease...
  11. doi request reprint Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment
    Hiromichi Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 254:320-5. 2011
    ..This study evaluates the significance of tumor involvement of the liver in early T-stage tumors and lymph node (LN) metastases on outcome after R0 resection of gallbladder cancer (GBCA)...
  12. ncbi request reprint Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer
    Raphael Araujo
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:4312-21. 2013
    ..Whether to administer chemotherapy as perioperative or adjuvant therapy remains controversial. We analyzed outcomes between these two treatment strategies...
  13. doi request reprint Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer
    Hiromichi Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg 247:994-1002. 2008
    ..The objective of this study was to evaluate the impact of postoperative morbidity on the long-term outcome after liver resection for MCRC...
  14. doi request reprint Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma
    Itaru Endo
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Ann Surg Oncol 15:2104-12. 2008
    ..Frozen section analysis of bile duct margins is often used to guide the extent of surgical resection for hilar cholangiocarcinoma (HCCA), but the usefulness of this practice is unknown...
  15. doi request reprint Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention
    Bridget N Fahy
    Department of Surgery, The Methodist Hospital, Houston, TX 77030, USA
    Ann Surg Oncol 16:361-70. 2009
    ..A multidisciplinary treatment approach which combines both medical and surgical modalities may be associated with improved survival...
  16. ncbi request reprint Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome
    William R Jarnagin
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 24:1152-60. 2006
    ..This clinicopathologic study characterizes differences in cell cycle-regulatory protein expression across the spectrum of BTA...
  17. pmc CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy
    Constantinos T Sofocleous
    Department of Interventional Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    J Vasc Interv Radiol 22:755-61. 2011
    ..To evaluate the clinical outcomes of percutaneous radiofrequency (RF) ablation of colorectal cancer liver metastases (CLMs) that recur after hepatectomy...
  18. ncbi request reprint Impact of steatosis on perioperative outcome following hepatic resection
    David A Kooby
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 7:1034-44. 2003
    ..Steatosis alone should not preclude aggressive hepatic resection for neoplasms when indicated; however, patients with marked steatosis undergoing large resections should still be approached with due caution...
  19. ncbi request reprint Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer
    Jurgen Weitz
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 21:4597-603. 2003
    ....
  20. ncbi request reprint Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma
    Jurgen Weitz
    Hepatobiliary Service and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Surgery 135:273-81. 2004
    ..Laparoscopy may reduce the rate of unnecessary laparotomy in these patients. However, there are no criteria for selective use of laparoscopy...
  21. doi request reprint Synchronous resection of primary and liver metastases for neuroendocrine tumors
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:4270-7. 2012
    ..Surgical approach is an accepted approach for metastatic neuroendocrine tumors (NET), but the safety and effectiveness of synchronous liver metastases resection with primary and/or locally recurrent NET is unclear...
  22. doi request reprint Resection of adrenocortical carcinoma liver metastasis: is it justified?
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:2643-51. 2012
    ..Adrenocortical carcinoma (ACC) liver metastases (LM) represent a therapeutic challenge, and it is unclear whether resection is justified. This study assesses long-term outcome and prognostic factors after liver resection for metastatic ACC...
  23. ncbi request reprint Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection
    Margo Shoup
    Departments of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Gastrointest Surg 7:325-30. 2003
    ..Preoperative assessment of future liver volume remaining distinguishes which patients undergoing liver resection will most likely benefit from preoperative liver enhancement techniques such as portal vein embolization...
  24. ncbi request reprint Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:2908-16. 2012
    ..We sought to assess the influence of obesity and body fat distribution on pathologic characteristics and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma...
  25. doi request reprint The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Surgery 151:518-25. 2012
    ..Cystic pancreatic endocrine neoplasms (CPENs) are uncommon tumors with uncertain disease biology and ill-defined diagnostic features...
  26. pmc Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
    Nancy E Kemeny
    Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Ave, New York, NY 10065, USA
    J Clin Oncol 27:3465-71. 2009
    ..Future randomized trials should compare HAI plus systemic chemotherapy with systemic therapy alone to assess the additional value of HAI therapy in converting patients with hepatic metastases to resectability...
  27. ncbi request reprint Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients
    Jason S Gold
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg 247:109-17. 2008
    ..We aimed to assess the evolution of the technical approach over time and correlations with morbidity, mortality, and oncologic outcome...
  28. doi request reprint Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection
    Itaru Endo
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 248:84-96. 2008
    ..This study analyzes changes in IHC frequency, demographics, and treatment outcome in a consecutive and single institutional cohort...
  29. ncbi request reprint Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients
    Peter J Allen
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 7:970-7. 2003
    ..Selection criteria identified in this study (symptoms, cyst size, solid component, and septations) and the utilization of new imaging techniques allow the creation of treatment plans for these patients that can be prospectively tested...
  30. doi request reprint Patterns of recurrence after ablation of colorectal cancer liver metastases
    T Peter Kingham
    Division of Hepatopancreatobiliary Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:834-41. 2012
    ..To determine the local recurrence rate and factors associated with recurrence after intraoperative ablation of colorectal cancer liver metastases...
  31. doi request reprint Kinetics of liver volume changes in the first year after portal vein embolization
    Danton Corrêa
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Arch Surg 145:351-4; discussion 354-5. 2010
    ..To determine the time course of liver hypertrophy after portal vein embolization (PVE)...
  32. doi request reprint Simple measurement of intra-abdominal fat for abdominal surgery outcome prediction
    Katherine Morris
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Arch Surg 145:1069-73. 2010
    ..To assess the effect of increasing body mass index, intra-abdominal fat, and outer abdominal fat on outcome in patients undergoing major hepatectomy...
  33. ncbi request reprint Differential diagnosis of proximal biliary obstruction
    Chandrakanth Are
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY 10021, USA
    Surgery 140:756-63. 2006
    ..However, in up to 15% of patients, hilar obstruction could be due to alternative diagnoses other than HCCA. The aim of this study was to determine preoperative criteria that could differentiate HCCA from the alternative diagnoses...
  34. doi request reprint Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases
    Anne M Covey
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 247:451-5. 2008
    ....
  35. ncbi request reprint Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    World J Surg 30:410-8. 2006
    ..The optimal abdominal incision for partial hepatectomy has not been established...
  36. ncbi request reprint The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas
    John C Mansour
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 10:1354-60. 2006
    ..We do not believe whole body FDG-PET to be essential in the evaluation of cystic lesions of the pancreas...
  37. ncbi request reprint Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma
    Carlos U Corvera
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 201:862-9. 2005
    ..Nontraumatic inflammatory hilar strictures are uncommon, but are known to mimic malignancy. This study examines the clinical and pathologic features of benign idiopathic strictures...
  38. doi request reprint Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases
    Joseph J Bennett
    Division of Hepatobiliary Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Ann Surg Oncol 15:1130-6. 2008
    ..This study uses standard pathologic analysis and immunohistochemistry (IHC) to determine the impact of occult metastatic disease to perihepatic LN in patients with colorectal cancer undergoing hepatectomy...
  39. doi request reprint Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases
    David J Gallagher
    Department of Medicine, Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center and Joan and Sanford Weill Medical College of Cornell University, New York, NY, USA
    Ann Surg Oncol 16:1844-51. 2009
    ..We investigated the relation between response to neoadjuvant chemotherapy and overall survival (OS) in patients with colorectal liver metastases (CLM)...
  40. ncbi request reprint Management of primary liver sarcomas
    Juürgen Weitz
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 109:1391-6. 2007
    ..Primary hepatic sarcoma is a rare entity. The objectives of the study were to define treatment and long-term outcome and to identify prognostic factors...
  41. doi request reprint Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases
    Anand Govindarajan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 444 E 68th Street, Room C887, New York, NY 10065, USA
    J Gastrointest Surg 15:1168-72. 2011
    ..To evaluate the role of intraoperative ablation as an adjunct to resection in patients with recurrent colorectal liver metastases (rCLM)...
  42. doi request reprint T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases
    Steven C Katz
    Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 16:2524-30. 2009
    ..This study examines the correlation between TIL numbers and survival following hepatic resection...
  43. doi request reprint Endoscopic ultrasound-guided transmural drainage of postoperative pancreatic collections
    Amy Tilara
    Gastroenterology and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
    J Am Coll Surg 218:33-40. 2014
    ..Data for endoscopic ultrasound (EUS)-guided drainage of postoperative fluid collections are limited. Here we report on the safety, efficacy, and timing of EUS-guided drainage of postoperative peripancreatic collections...
  44. ncbi request reprint Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Am Coll Surg 198:570-6. 2004
    ..Few reports have discussed the utility of this procedure and its indications are poorly defined. The aim of this study was to review our experience with MHP...
  45. ncbi request reprint Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases
    Stephen R Grobmyer
    Department of Surgery, Division of Hepatobiliary Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Arch Surg 139:1326-30. 2004
    ..2) Preventing unnecessary celiotomy in these patients undergoing laparoscopy is associated with shorter hospital stays and earlier administration of systemic chemotherapy...
  46. pmc Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma
    Jurgen Weitz
    Hepatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 241:269-76. 2005
    ..To define perioperative and long-term outcome and prognostic factors in patients undergoing hepatectomy for liver metastases arising from noncolorectal and nonneuroendocrine (NCNN) carcinoma...
  47. ncbi request reprint Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer?
    Joseph J Bennett
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 201:503-10. 2005
    ..In the context of a followup program after curative gastrectomy, recurrence and survival were investigated for patients presenting with either symptomatic or asymptomatic recurrence...
  48. doi request reprint Polypoid lesions of the gallbladder: diagnosis and followup
    Hiromichi Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 208:570-5. 2009
    ..The aims of this study were to assess the natural history and the histologic characteristics of US-detected PLG...
  49. ncbi request reprint Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases
    Sam S Yoon
    Department of Surgery, Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Yawkey 7B 7926, 55 Fruit Street, Boston, Massachusetts 02114, USA
    Ann Surg Oncol 13:353-62. 2006
    ..Circulating angiogenic factors in patients with colorectal cancer liver metastases may promote tumor growth and contribute to liver regeneration after partial hepatectomy...
  50. ncbi request reprint Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer
    Siobhan M Kehoe
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, NY 10021, USA
    Gynecol Oncol 112:496-500. 2009
    ..To determine the incidence, management, and outcome of patients diagnosed with a pancreatic leak after a distal pancreatectomy during primary surgical cytoreduction for ovarian, peritoneal, or tubal cancer...
  51. doi request reprint Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Mod Pathol 24:1221-8. 2011
    ..The prognostic value of FRα expression and the utility of FRα-targeted therapies in stage-IV colorectal cancer patients deserve further exploration...
  52. ncbi request reprint 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer
    Carlos U Corvera
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 206:57-65. 2008
    ..The role of PET in detecting disease recurrence after resection was also examined...
  53. ncbi request reprint Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy
    Camelia S Sima
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 250:914-21. 2009
    ..To develop 2 instruments that predict the probability of perioperative red blood cell transfusion in patients undergoing elective liver resection for primary and secondary tumors...
  54. doi request reprint Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab
    Andrea Cercek
    Department of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 21:479-86. 2014
    ..Systemic bevacizumab (Bev) was added to hepatic arterial infusion (HAI) floxuridine (FUDR)-based chemotherapy in three studies in an attempt to improve outcomes. A specific review of biliary toxicity was carried out...
  55. pmc Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome
    Michael D'Angelica
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 239:400-8. 2004
    ..To define the natural history of resected intraductal papillary mucinous neoplasms (IPMN) of the pancreas and to identify clinical and pathologic prognostic features...
  56. ncbi request reprint Recurrent invasive intraductal papillary mucinous carcinoma of the pancreas mimicking pott disease: review of the literature
    Carlos U Corvera
    Department of Surgery, University of California, San Francisco, Calif, USA
    Pancreas 32:321-4. 2006
    ..In our review of published reports in patients who underwent resection of IPMN, we found a combined mean recurrence rate of approximately 20%...
  57. ncbi request reprint Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm
    Mary Maluccio
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Vasc Interv Radiol 16:955-61. 2005
    ....
  58. ncbi request reprint Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer
    Nancy Kemeny
    Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 23:4888-96. 2005
    ..To determine the maximum-tolerated dose (MTD) of concurrent systemic oxaliplatin (Oxal) combinations plus hepatic arterial infusion (HAI) in patients with unresectable hepatic metastases from colorectal cancer...
  59. pmc Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma
    William R Jarnagin
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 241:703-12; discussion 712-4. 2005
    ..The current study compares outcome after resection of papillary hilar cholangiocarcinoma to that of the more common nodular-sclerosing subtype...
  60. doi request reprint A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years
    Raymond H Thornton
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 115:5000-6. 2009
    ....
  61. ncbi request reprint Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies
    William R Jarnagin
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 98:1689-700. 2003
    ....
  62. ncbi request reprint c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival
    Celina Su Ping Ang
    Weill Medical College at Cornell University, Department of Medicine, New York, NY, USA
    Anticancer Res 33:3241-5. 2013
    ..We assessed c-MET and HGF expression in 49 patients with early-stage HCC and correlated the results with disease characteristics and survival...
  63. doi request reprint Current role of therapeutic laparoscopy and thoracoscopy in the management of malignancy: a review of trends from a tertiary care cancer center
    Chandrakanth Are
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 206:709-18. 2008
  64. pmc Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract
    George Miller
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Exp Clin Cancer Res 28:62. 2009
    ..The pathogenesis of biliary cancers is ill-defined. This study investigates changes in gene expression and copy number in biliary cancers and correlates these changes with anatomical site of origin, histopathology and outcome...
  65. pmc Surgical treatment of hepatocellular carcinoma: expert consensus statement
    William Jarnagin
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    HPB (Oxford) 12:302-10. 2010
    ..Whether ablation of small tumors provides long term disease control that is comparable to resection remains unclear...
  66. pmc A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients
    Peter J Allen
    Memorial Sloan Kettering Cancer Center, USA
    Ann Surg 244:572-82. 2006
    ..To define a group of patients with pancreatic cysts who do not require resection...
  67. doi request reprint Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases
    T Peter Kingham
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Surg Oncol 102:988-95. 2010
    ..The role of hepatic arterial infusional therapy in treating hepatic colorectal metastases includes treating patients with both resectable and unresectable metastases in the adjuvant, neoadjuvant, or palliative settings...
  68. ncbi request reprint Extrahepatic bile duct carcinoid tumors: malignant biliary obstruction with a good prognosis
    Cristina R Ferrone
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 205:357-61. 2007
  69. doi request reprint Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms
    Rebekah White
    Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 206:445-50. 2008
    ..The routine use of staging laparoscopy in patients with radiographically resectable pancreatic and peripancreatic neoplasms remains controversial...
  70. ncbi request reprint Laparoscopic adrenalectomy for isolated adrenal metastasis
    Vivian E Strong
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 14:3392-400. 2007
    ....
  71. pmc Comparative genomic analysis of primary versus metastatic colorectal carcinomas
    Efsevia Vakiani
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 30:2956-62. 2012
    ..To compare the mutational and copy number profiles of primary and metastatic colorectal carcinomas (CRCs) using both unpaired and paired samples derived from primary and metastatic disease sites...
  72. doi request reprint Resection of perihilar biliary schwannoma
    Lucian Panait
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Surg Oncol 20:e157-9. 2011
    ..Patients generally lack symptoms and seek medical attention when tumor growth causes obstructive jaundice. Preoperative diagnosis is difficult and resection is the treatment of choice...
  73. doi request reprint Recurrence patterns of intraductal papillary mucinous neoplasms of the pancreas on enhanced computed tomography
    Jonathan Landa
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Comput Assist Tomogr 33:838-43. 2009
    ..To characterize imaging features and findings in recurrent intraductal papillary mucinous neoplasms (IPMN); thereby reconciling the "field defect" theory with the appearance of recurrences distant from the resection margin...
  74. ncbi request reprint The international position on laparoscopic liver surgery: The Louisville Statement, 2008
    Joseph F Buell
    Department of Surgery, Director of Transplantation, Jewish Hospital Transplant Center, 200 Abraham Flexner Way, Louisville, KY 40202, USA
    Ann Surg 250:825-30. 2009
    ..To summarize the current world position on laparoscopic liver surgery...
  75. doi request reprint Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation
    Flavio G Rocha
    Hepatopancreatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Surg Oncol 102:968-74. 2010
    ..This review will focus on the application and outcome of these techniques in patients with colorectal liver metastases...
  76. ncbi request reprint Randomized clinical trials in gastric cancer
    Sharon M Weber
    Section of Surgical Oncology, University of Wisconsin Hospital, Madison, USA
    Surg Oncol Clin N Am 11:111-31, ix. 2002
    ..In comparison, there were only six surgical trials evaluating the extent of either primary resection or lymphadenectomy...
  77. ncbi request reprint Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry
    Ki Young Chung
    Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, H 816, New York, NY 10021, USA
    J Clin Oncol 23:1803-10. 2005
    ....
  78. ncbi request reprint Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study
    Jinru Shia
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Mod Pathol 18:1350-6. 2005
    ..Additional studies are needed to determine whether epidermal growth factor receptor gene amplification bears any informative value in predicting response to cetuximab-based therapy...
  79. ncbi request reprint Antibody-based therapies for colorectal cancer
    Ki Young Chung
    Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Oncologist 10:701-9. 2005
    ..South San Francisco, CA, http://www.gene.com) and cetuximab (Erbitux; ImClone Systems, Inc., New York, http://www.imclone.com), in colorectal cancer...
  80. ncbi request reprint Adjuvant therapy of colon cancer: current status and future directions
    Ki Young Chung
    Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021 and Weill Medical College of Cornell University, Ithaca, USA
    Cancer J 13:192-7. 2007
    ....
  81. ncbi request reprint Cetuximab therapy and symptomatic hypomagnesemia
    Deborah Schrag
    Division of Gastrointestinal Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 221, New York, NY 10011, USA
    J Natl Cancer Inst 97:1221-4. 2005
    ..Because symptoms may be rapidly ameliorated with supplementation, we suggest that, when fatigue or hypocalcemia is encountered during cetuximab therapy, serum magnesium level be measured and repleted as necessary...
  82. ncbi request reprint Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells
    Malcolm A S Moore
    Moore Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Exp Hematol 35:105-16. 2007
    ..To model human leukemogenesis by transduction of human hematopoietic stem cells (HSC) with genes associated with leukemia and expressed in leukemic stem cells...
  83. pmc Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation
    Jan Jacob Schuringa
    Laboratory of Developmental Hematopoiesis, Cell Biology Program, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Exp Med 200:623-35. 2004
    ..Our data indicate that a persistent activation of STAT5A in human hematopoietic stem and progenitor cells results in their enhanced self-renewal and diverts differentiation to the erythroid lineage...
  84. ncbi request reprint Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis
    Ki Young Chung
    Laboratory of Developmental Hematopoiesis, Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Blood 105:77-84. 2005
    ..Flt3-ITD+ acute myeloid leukemia (AML) blasts from patients invariably generated early AG1295-sensitive CAs in MS-5 cocultures, further validating the phenotype observed in transduced CD34+ cells...
  85. doi request reprint Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy
    JEREMIAH L DENEVE
    Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
    Ann Surg Oncol 16:640-8. 2009
    ..Liver cell adenoma (LCA) is a benign hepatic tumor with poorly characterized risk for spontaneous rupture and malignant transformation...
  86. pmc CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
    Sergey V Shmelkov
    Howard Hughes Medical Institute, Ansary Center for Stem Cell Therapeutics, and Department of Genetic Medicine, Weill Medical College of Cornell University, New York, New York, USA
    J Clin Invest 118:2111-20. 2008
    ....
  87. ncbi request reprint Defining palliative surgery in patients receiving noncurative resections for gastric cancer
    Thomas J Miner
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 198:1013-21. 2004
    ..The literature to date is limited by the imprecise use of the term palliative and subsequent variable designation of patients into evaluable groups...
  88. pmc Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma
    Abeezar I Sarela
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 243:189-95. 2006
    ..For patients with laparoscopic stage M1 gastric adenocarcinoma, no resection of the primary tumor, and systemic chemotherapy, this study investigated the incidence of subsequent palliative intervention and survival...
  89. ncbi request reprint Regional and systemic chemotherapy for primary hepatobiliary cancers and for colorectal cancer metastatic to the liver
    Ki Young Chung
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Radiat Oncol 15:284-98. 2005
    ..Therefore, the regional approach for hepatobiliary tumors deserves further investigation as well as randomized trials for adequate comparison to new systemic chemotherapies...
  90. ncbi request reprint Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer
    Dennis S Chi
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, NY 10021, USA
    Gynecol Oncol 101:224-7. 2006
    ..The purpose of this study was to report the outcomes of a series of patients who underwent splenectomy for persistent or recurrent ovarian cancer via laparoscopy or hand-assisted laparoscopy...
  91. ncbi request reprint Selection of patients with gastric adenocarcinoma for laparoscopic staging
    Abeezar I Sarela
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Am J Surg 191:134-8. 2006
    ..To refine selection criteria for laparoscopic staging of gastric adenocarcinoma, preoperatively available clinical and radiologic factors that may predict the risk of M1 disease were investigated...
  92. pmc Biologic predictors of survival in node-negative gastric cancer
    David A Kooby
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg 237:828-35; discussion 835-7. 2003
    ..To evaluate factors predictive of survival following curative resection for node-negative gastric adenocarcinoma...
  93. ncbi request reprint Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer
    Abeezar I Sarela
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg Oncol 11:380-6. 2004
    ..This study examined prognostic discrimination by lymph node staging for duodenal adenocarcinoma and compared the nodal stage-specific survival with that associated with gastric antral adenocarcinoma...
  94. ncbi request reprint Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma
    Abeezar I Sarela
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 10:783-91. 2003
    ..This study examined whether prognostic discrimination is improved by distinguishing between pT2 tumors limited to the muscularis propria (MP) and those extending to subserosa (SS)...
  95. ncbi request reprint Port site metastasis after diagnostic laparoscopy for upper gastrointestinal tract malignancies: an uncommon entity
    Margo Shoup
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 9:632-6. 2002
    ..This study was designed to examine the incidence of port site metastasis and open incision site metastasis for upper gastrointestinal tract (GI) malignancies...
  96. ncbi request reprint Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, C1275 New York, NY 10021, USA
    J Clin Oncol 21:3647-50. 2003
    ..We developed and internally validated a nomogram that combines these factors to predict the probability of 5-year gastric cancer-specific survival on the basis of 1,039 patients treated at a single institution...
  97. pmc The diminishing role of surgery in the treatment of gastric lymphoma
    Sam S Yoon
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    Ann Surg 240:28-37. 2004
    ..This article reviews the pathogenesis, diagnosis, and treatment of patients with primary gastric lymphoma, with special attention to the changing role of surgery...
  98. ncbi request reprint Gastrectomy for gastric cancer: defining critical elements of patient selection and outcome assessment
    Thomas J Miner
    Department of Surgery, Brown Medical School, 593 Eddy Street, APC 439, Providence, RI 02903, USA
    Surg Oncol Clin N Am 13:455-66, viii. 2004
    ..Studies designed to measure palliative interventions would benefit from precise designations of palliative intent inpatients receiving non-curative operations...
  99. ncbi request reprint Surgical approaches and outcomes in the treatment of gastric cancer
    Hong Jin Kim
    Department of Surgery, University of North Carolina, Chapel Hill, NC, USA
    Semin Radiat Oncol 12:162-9. 2002
    ..Patient selection remains critical, limiting the role of surgery in advanced disease and reserving aggressive surgical resection for patients with high curative potential...